Reckitt Benckiser

Public consensus   -   Last updated 22/07/20

Contributors

  • 17 H1 FY20 based on
  • 17 FY20 based on
  • 17 Q2 FY20 based on
  • 17 FY21 based on
  • 17 FY22 based on
Reporting currency: GBP
Reporting unit: Millions
H1 FY20
CONSENSUS
22/07/20
FY20
CONSENSUS
22/07/20
Q2 FY20
CONSENSUS
22/07/20
FY21
CONSENSUS
22/07/20
FY22
CONSENSUS
22/07/20
Reckitt Benckiser Group Plc
Net Revenue Growth: Like for Like %
IFCN
(3.1)
(0.6)
(4.7)
2.4
3.4
OTC
15.6
8.4
(5.1)
0.6
4.1
Other
18.7
12.9
19.9
0.9
4.5
Total Health
9.4
6.6
4.6
1.4
4.0
Hygiene Home
13.0
9.1
12.9
1.9
4.0
Group growth: like-for-like %
10.6
7.5
7.8
1.4
3.9
Net M&A impact %
0.1
0.2
0.2
n/a
-
FX impact %
(1.5)
(1.7)
(2.0)
0.0
(0.6)
Group growth: Net Revenue growth (Actual rates) - continuing operations %
9.2
5.9
5.8
1.4
3.7
Net Revenue - Total Reported £
IFCN
1,456
2,918
710
2,987
3,088
OTC
1,005
2,082
390
2,091
2,175
Other
1,692
3,201
864
3,226
3,363
Total Health
4,145
8,197
1,956
8,309
8,632
Hygiene Home
2,662
5,390
1,307
5,472
5,659
Total Net Revenue
6,807
13,587
3,263
13,781
14,291
Operating Profit - Adjusted
Health
954
1,901
n/a
1,925
2,074
Hygiene Home
584
1,295
n/a
1,310
1,388
Total Operating Profit - Adjusted
1,538
3,195
n/a
3,236
3,462
Operating Margin % - Adjusted
Health
23.0
23.2
n/a
23.2
24.0
Hygiene Home
21.9
24.0
n/a
23.9
24.5
Total Operating Margin % - Adjusted
22.6
23.5
n/a
23.5
24.2
Net Finance Expense - Adjusted
(157)
(304)
n/a
(279)
(250)
Taxation (expense)/benefit - Adjusted
(318)
(660)
n/a
(676)
(735)
Non-controlling Interest
(9)
(14)
n/a
(14)
(15)
Continuing Operations
Net income - adjusted
1,099
2,226
n/a
2,277
2,463
Average number of shares on a diluted basis
710.0
710.5
n/a
712.0
713.5
EPS, Group, fully diluted, adjusted (p)
154.8
313.4
n/a
319.9
345.3

Disclaimer

Earnings forecasts are produced by the contributing registered investment analysts currently covering RB.

The estimates that are used to compile the consensus are the sole responsibility of the registered investment
analysts. RB uses Vuma to compile the consensus information, and does not endorse or concur with such analyst
information, conclusions or recommendations. RB has not verified any of the information received and none of RB,
its affiliates or any of its or their respective directors, officers and employees make any representation or warranty,
express or implied, as to, or accepts any responsibility for, the accuracy or completeness of the consensus
information. RB shall not be liable (whether in contract, tort or otherwise) for any errors, inaccuracies or omissions in
the content of the information (either at the date of issue of these forecasts, or any other date), or for any action
taken in reliance thereon. RB does not assume any responsibility to update, revise or supplement such information.

The information provided by RB is for information purposes only and is not intended for trading purposes. It should
be noted that forecasts are forward-looking and are therefore subject to risks and uncertainties (including unknown
risks and uncertainties) that may materially affect eventual results.

THE FORECASTS PROVIDED ARE BASED ON A MEAN AVERAGE OF ESTIMATES PROVIDED AND DO NOT
REPRESENT OR REFLECT, AND SHOULD NOT BE DEEMED TO BE, RB'S OPINIONS, ESTIMATES OR
FORECASTS.